 LYON, France and CAMBRIDGE, Mass., Oct. 26, 2020 GLOBE NEWSWIRE -- ERYTECH Pharma Nasdaq Euronext: ERYP, a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced the appoint ment of Dr. Stewart Craig as its Chief Techn ical O fficer CTO and member of the executive team. D r. Craig brings 3 5 years of experience in the development, manufactur ing , technical operations, quality systems and regulatory affairs for complex biologics and cell gene therapies worldwide. 